EpiPen manufacturer posts third-quarter losses of $119.8M

EpiPen manufacturer posts third-quarter losses of $119.8M


Mylan , the company that manufacturers the EpiPen , posted third-quarter losses of $119.8 million on Wednesday. The company, which manufactures the emergency allergy injector, had set aside over $465 million in anticipation of a settlement with the federal government over Medicaid rebates.



from Biotech News